首页> 外文学位 >Predictors of use of hydroxyurea and its impact on clinical and economic outcomes among children with sickle cell disease.

【24h】

Predictors of use of hydroxyurea and its impact on clinical and economic outcomes among children with sickle cell disease.

机译：镰状细胞病患儿中羟基脲的使用及其对临床和经济结果的影响的预测因素。

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Datar, Manasi.;
展开▼
作者单位

The University of Mississippi.;

展开▼
授予单位 The University of Mississippi.;
学科 Pharmaceutical sciences.;Individual family studies.;Health care management.;Public health.;Social research.
学位 Ph.D.
年度 2015
页码 176 p.
总页数 176
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-17 11:52:46

相似文献

外文文献
中文文献
专利

1. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. [J] . Brandow AM, Panepinto JA American Journal of Hematology . 2011,第9期

机译：监测镰状细胞病患儿的羟基脲的毒性，影响和依从性。
2. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. [J] . Koren A, Segal Kupershmit-D, Zalman L, Pediatric Hematology and Oncology . 1999,第3期

机译：羟基脲在镰状细胞性贫血中的作用：针对患有严重镰状细胞性贫血和镰状细胞β-地中海贫血的儿童和青少年的临床试验。
3. Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes | Haematologica [J] . M de Montalembert, V Brousse, C Elie, Haematologica . 2006,第1期

机译：镰状细胞病患儿的长期羟基脲治疗：耐受性和临床结果血液学
4. A comparative study of linear and quadratic discriminant classifier techniques for variable selection: a case study in predicting the effectiveness of hydroxyurea treatment of sickle cell anemia [C] . Roushanzamir, S., Valafar, . 1999

机译：线性和二次判别式分类器技术用于变量选择的比较研究：预测羟基脲治疗镰状细胞性贫血有效性的案例研究
5. Medication adherence and associated outcomes in Medicaid enrollees with sickle cell disease. [D] . Candrilli, Sean D. 2009

机译：镰状细胞病医疗补助参加者的药物依从性和相关结果。
6. Hydroxyurea Use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes? [O] . Susan E. Creary, Deena J. Chisolm, Terah L. Koch, -1

机译：镰状细胞病患儿使用羟基脲：重症患者会否使用羟基脲是否会影响住院治疗效果？
7. Combination of Exchange Transfusion Treatment and Hydroxyurea Cause Beneficial Changes to Laboratory Parameters and Clinical Outcome in Patients with Sickle Cell Disease/β Thalassemia Compared with Hydroxyurea or Exchange Transfusion Alone [O] . Sophia Delicou 2016

机译：交换输血处理和羟基脲的组合导致镰状细胞疾病患者的实验室参数和临床结果与单独的羟基脲或交换输血相比，对镰状细胞疾病/β的患者患者进行了有益的变化
8. Hydroxyurea for the Treatment of Sickle Cell Disease. Evidence Report/Technology Assessment No. 165 [R] . Segal, J. B. , Strouse, J. J. , Beach, M. C. , 2008

机译：羟基脲治疗镰状细胞病。第165号证据报告/技术评估

Predictors of use of hydroxyurea and its impact on clinical and economic outcomes among children with sickle cell disease.

著录项

相似文献

相关主题

期刊订阅